Cargando…
Thoratec CentriMag for Temporary Treatment of Refractory Cardiogenic Shock or Severe Cardiopulmonary Insufficiency: A Systematic Literature Review and Meta-Analysis of Observational Studies
The aim of the study was to systematically evaluate effect of CentriMag heart pump (Thoratec Corporation) as temporary ventricular assist device (VAD) and part of extracorporeal membrane oxygenation (ECMO) system on outcomes in patients with cardiac or cardiac-respiratory failure. A systematic searc...
Autores principales: | Borisenko, Oleg, Wylie, Gillian, Payne, John, Bjessmo, Staffan, Smith, Jon, Yonan, Nizar, Firmin, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154791/ https://www.ncbi.nlm.nih.gov/pubmed/25010916 http://dx.doi.org/10.1097/MAT.0000000000000117 |
Ejemplares similares
-
Use of CentriMag for refractory cardiogenic shock in a puerperal woman: case report
por: Pêgo-Fernandes, Paulo Manuel, et al.
Publicado: (2021) -
Extracorporeal Life Support and Temporary CentriMag Ventricular Assist Device to Salvage Cardiogenic-Shock Patients Suffering from Prolonged Cardiopulmonary Resuscitation
por: Chen, Jia-Lin, et al.
Publicado: (2022) -
Thoratec Centrimag VAD for cardiogenic shock – a developing country experience
por: Villavicencio, M, et al.
Publicado: (2013) -
Outcome of CentriMag™ extracorporeal mechanical circulatory support use in critical cardiogenic shock (INTERMACS 1) patients
por: Mehta, Vipin, et al.
Publicado: (2020) -
Hemocompatibility of new magnetically-levitated centrifugal pump technology compared to the CentriMag adult pump
por: Schibilsky, David, et al.
Publicado: (2020)